Image-Guided Radiation Therapy Global Market Report 2024

The image-guided radiation therapy market size has grown strongly in recent years. It will grow from $1.78 billion in 2023 to $1.89 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historic period can be attributed to factors such as the increasing pace of industrialization, the need for quality assurance, adherence to regulatory compliance, the expansion of infrastructure projects, and the globalization of supply chains.

The image-guided radiation therapy market size is expected to see steady growth in the next few years. It will grow to $2.3 billion in 2028 at a compound annual growth rate (CAGR) of 5%. The anticipated growth in the forecast period can be attributed to ongoing infrastructure development, changes in the regulatory landscape, the expansion of renewable energy initiatives, a heightened focus on sustainable practices, and an increase in aerospace and automotive production. Major trends expected in the forecast period encompass miniaturization and portability, advancements in x-ray tube technology, the adoption of digital radiography, the integration of artificial intelligence (AI), and customization tailored for specific applications.

The growth of the image-guided radiation therapy market is anticipated to be propelled by the rising incidence of cancer. Cancer, characterized by the uncontrolled proliferation and dissemination of abnormal cells in the body, has led to an increased demand for image-guided radiation therapy (IGRT) in cancer treatment. IGRT is favored for its precision and accuracy in delivering radiation to cancer cells, minimizing damage to healthy tissue, and reducing associated side effects. In January 2022, the American Cancer Society reported an expected rise in newly diagnosed cancer cases to around 2 million, marking a significant increase of over 10% compared to the 1.8 million cases reported in 2021. Consequently, the growing prevalence of cancer is a key driver for the future expansion of the image-guided radiation therapy market.

The expansion of the image-guided radiation therapy market is also being propelled by an increase in healthcare spending. Healthcare spending, denoting the total financial resources allocated to the healthcare sector in a specific region or country, plays a crucial role in optimizing cancer treatment through the implementation of image-guided radiation therapy. This technology enhances precision and accuracy in radiation delivery, leading to improved patient outcomes, reduced treatment side effects, and long-term cost savings by ensuring targeted and effective cancer care. In May 2023, a report from the UK's Office for National Statistics revealed that the total healthcare expenditure in the UK for 2021 was $367.25 billion (£280.7 billion), with pharmaceutical expenditure reaching $51.84 billion (£39.6 billion) and preventive care spending doubling to $45.93 billion (£35.1 billion) from 2020. Hence, the upsurge in healthcare spending is a significant factor driving the growth of the image-guided radiation therapy market in the foreseeable future.

The growth of the image-guided radiation therapy market is expected to be hindered by the shortage of skilled radiologists. Limited accessibility and affordability, quality assurance challenges, and potential slowdowns in research initiatives may impede advancements in the field. A 2023 report by ManpowerGroup revealed a deficit of radiologists in Europe, with only 13 radiologists per 100,000 population, and the U.K. having less than 10, resulting in only 30 radiologists per million population. This scarcity of skilled radiologists is a significant constraint on the image-guided radiation therapy market's expansion.

Leading companies in the image-guided radiation therapy market are prioritizing technological advancements. For example, Cenos, an online adaptive therapy option for radiotherapy treatments, allows healthcare professionals to promptly modify a radiation therapy treatment plan if needed during the patient's ongoing treatment. In October 2023, Accuray Incorporated partnered with Limbus AI to launch the Cenos platform for its Radixact System, providing compromise-free capabilities for treating various cancer cases. The platform enables online adjustments to treatment plans between sessions.

In May 2022, Brainlab AG, a German medical technology company, acquired medPhoton GmbH, a move aimed at strengthening capabilities in intraoperative imaging. The acquisition enhances innovative potential, particularly for Brainlab AG's Loop-X imaging robot, and expands access to cutting-edge surgery technology. medPhoton GmbH, based in Austria, specializes in developing robotic imaging solutions for navigational surgery and image-guided radiation therapy.

Major companies operating in the image-guided radiation therapy market report are Hitachi Ltd., Toshiba Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare Company, Varian Medical Systems Inc., Elekta AB, Canon Medical Systems R&D (Dalian) Co. Ltd., Accuray Incorporated, Ion Beam Applications S.A., Brainlab AG, ViewRay Technologies Inc., Mevion Medical Systems Inc., RaySearch Laboratories AB, Vision RT Ltd. , Sun Nuclear Corporation, IZI Medical Products LLC, Eckert & Ziegler BEBIG GmbH, C-RAD AB, Standard Imaging Inc., CIVCO Radiotherapy Inc., IntraOp Medical Corporation, RTsafe Solutions Ltd., ASG Superconductors S.p.A., Mirada Medical Corporation, Xstrahl Ltd., Mobius Medical Systems LP, Precision X-Ray Inc., RefleXion Medical Inc., Panacea Medical Technologies Pvt. Ltd..

North America was the largest region in the image-guided radiation therapy market in 2023. The regions covered in the image-guided radiation therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the image-guided radiation therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Image-guided radiation therapy (IGRT) is a medical technique used in radiation oncology to deliver precise and targeted radiation treatment to cancerous tumors. This approach aims to reduce treatment toxicity and enables the safe administration of more accurate radiation doses to patients with cancer.

The main product types of image-guided radiation therapy include 4D gating and 4D RT, linear accelerator (linac), PET and MRI-guided radiation therapy, portal imaging, and CT scanning. 4D Gating and 4D RT involve monitoring and synchronizing a patient's respiratory or cardiac motion with the delivery of radiation or imaging, ensuring accurate targeting of the treatment or imaging. Various procedures associated with IGRT include intensity-modulation radiation therapy, 3D conformal radiation therapy, stereotactic therapy, proton beam therapy, and particle therapy. Applications of IGRT encompass treating conditions such as lung cancer, prostate cancer, head and neck cancer, gynecological cancer, gastrointestinal cancer, and others. End-users of IGRT include hospitals and independent radiotherapy centers.

The image-guided radiation therapy market research report is one of a series of new reports that provides image-guided radiation therapy market statistics, including image-guided radiation therapy industry global market size, regional shares, competitors with image-guided radiation therapy market share, detailed image-guided radiation therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the image-guided radiation therapy industry. This image-guided radiation therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The image-guided radiation therapy market includes revenues earned by entities by providing treatment using various imaging technological services such as positron emission tomography, 2D radiotherapy technology, and 3D radiotherapy technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The image-guided radiation therapy market consists of sales of cone-beam imaging systems, immobilization devices, ultrasound imaging, adaptive radiation therapy systems, and cameras. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.